Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Protokinetix Inc
(OP:
PKTX
)
0.0119
+0.0037 (+45.12%)
Streaming Delayed Price
Updated: 3:27 PM EDT, Sep 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Protokinetix Inc
Research Paper Incorporating ProtoKinetix AAGP® Submitted to Scientific Journal for Publication
June 06, 2023
From
ProtoKinetix, Incorporated
Via
Business Wire
ProtoKinetix Successfully Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell Transplants
July 20, 2022
From
ProtoKinetix, Incorporated
Via
Business Wire
ProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually Only
January 14, 2022
From
ProtoKinetix, Incorporated
Via
Business Wire
ProtoKinetix Announces Selection of AAGP® Candidate Formulations for Treatment of Dry Eye Disease
November 23, 2021
From
ProtoKinetix, Incorporated
Via
Business Wire
ProtoKinetix and IQVIA Partner to Support Development of AAGP® Product in the Treatment of Ocular Conditions
May 12, 2021
From
ProtoKinetix, Incorporated
Via
Business Wire
ProtoKinetix Announces the Resumption of Phase 1b Clinical Trials for the use of AAGP® Treated Islet Cells in the Treatment of Type 1 Diabetes
April 22, 2021
From
ProtoKinetix, Incorporated
Via
Business Wire
ProtoKinetix Engages Multi-National Partner for Formulation of Topical Drug to Treat Dry Eye Disease & Ocular Inflammation with AAGP®
April 14, 2021
From
ProtoKinetix, Incorporated
Via
Business Wire
Journal of Tissue Engineering and Regenerative Medicine Publishes Peer Reviewed Research Paper Establishing ProtoKinetix AAGP® Enhanced Stem Cell Vision Restoration
April 07, 2021
From
ProtoKinetix, Incorporated
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.